ProCE Banner Activity

AAML0631: Adding ATO to Consolidation Therapy in Pediatric APL

Slideset Download
Conference Coverage
In this phase III study, addition of ATO allowed anthracycline dose to be reduced; event-free survival improved over historic controls.

Released: December 08, 2015

Expiration: December 06, 2016

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Millennium Takeda

Seagen